CLOV Form 144: 175000 Shares Proposed Sale

CLOV reported a proposed sale of 175000 common shares under a Form 144.

Rhea-AI Filing Summary

CLOV reported a proposed sale of 175000 common shares under a Form 144. The filing lists a broker-dealer Morgan Stanley Smith Barney LLC Executive Financial Services and shows transaction details dated 03/04/2026.

The filing also itemizes restricted stock lots with grant/vesting dates: 57,627 (10/18/2025), 69,009 (01/18/2026) and 48,364 (10/15/2025).

Insights

Securities Compliance Counsel

Form 144 filed reporting a broker-handled proposed disposition of 175000 shares.

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the broker-dealer and records the filing date as 03/04/2026. It lists restricted stock tranches of 57,627, 69,009 and 48,364 associated with dates in 2025 and 2026.

Form 144 is a notice of an intended sale under Rule 144; actual execution, timing, and proceeds depend on subsequent transactions and are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Clover's (CLOV) Form 144 report?

The Form 144 reports a proposed sale of 175000 common shares, filed with a broker-dealer on 03/04/2026. It lists restricted stock tranches of 57,627, 69,009, and 48,364 with corresponding grant dates.

Who is the broker handling the reported CLOV sale?

The broker-dealer listed is Morgan Stanley Smith Barney LLC Executive Financial Services. The filing names the firm and its New York address, indicating broker involvement in the proposed disposition.

Do the listed restricted stock amounts equal the total being sold?

The filing shows restricted stock lots of 57,627, 69,009, and 48,364, and separately lists 175000 shares proposed for sale. The excerpt does not state whether those tranches compose the entire 175000 total.

Does Form 144 guarantee the shares were sold?

No; Form 144 is a notice of an intended sale under Rule 144, not proof of completion. Execution, timing, and proceeds are determined by subsequent brokerage transactions not shown in the excerpt.

Where can I find the filing date for CLOV's Form 144?

The excerpt displays the filing date as 03/04/2026. That date is the record shown in the content and relates to the Form 144 submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 05:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001938197
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLOVER HEALTH INVESTMENTS, CORP.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	(201) 432-2133
Name of Person for Whose Account the Securities are To Be Sold	BRADY PRIEST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	175000	378945.00	428951430	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/18/2025	Restricted Stock	Issuer			57627	10/18/2025	Not Applicable
Common	01/18/2026	Restricted Stock	Issuer			69009	01/18/2026	Not Applicable
Common	10/15/2025	Restricted Stock	Issuer			48364	10/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brady Patrick Priest
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)